Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.

× No keyword cloud information.

17 in total

1. Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.

Authors: Joseph A Sparano; Eduard Vrdoljak; Oliver Rixe; Binghe Xu; Alexey Manikhas; Carlos Medina; Susanne Crocamo Ventilari Da Costa; Jungsil Ro; Gonzalo Rubio; Monica Rondinon; Gumersindo Perez Manga; Ronald Peck; Valerie Poulart; Pierfranco Conte
Journal: J Clin Oncol Date: 2010-06-07 Impact factor: 44.544

2. Weekly ixabepilone administration in heavily pretreated metastatic breast cancer patients.

Authors: Ellen B Kossoff; Nuttapong Ngamphaiboon; Thomas J Laudico; Tracey L O'Connor
Journal: Med Oncol Date: 2010-10-27 Impact factor: 3.064

3. Phase I trial of ixabepilone plus pegylated liposomal doxorubicin in patients with adenocarcinoma of breast or ovary.

Authors: E Chuang; N Wiener; P Christos; R Kessler; M Cobham; D Donovan; G L Goldberg; T Caputo; A Doyle; L Vahdat; J A Sparano
Journal: Ann Oncol Date: 2010-03-31 Impact factor: 32.976

Review 4. Overall survival as the outcome for randomized clinical trials with effective subsequent therapies.

Authors: Edward L Korn; Boris Freidlin; Jeffrey S Abrams
Journal: J Clin Oncol Date: 2011-05-09 Impact factor: 44.544

5. Phase II trial of sagopilone, a novel epothilone analog in metastatic melanoma.

Authors: R C DeConti; A P Algazi; S Andrews; P Urbas; O Born; D Stoeckigt; L Floren; J Hwang; J Weber; V K Sondak; A I Daud
Journal: Br J Cancer Date: 2010-10-05 Impact factor: 7.640

Review 6. Ixabepilone as monotherapy or in combination for the treatment of advanced breast cancer.

Authors: Erin M Bertino; Bhuvaneswari Ramaswamy
Journal: Breast Cancer (Dove Med Press) Date: 2010-05-24

7. Phase II study of gemcitabine and carboplatin in metastatic breast cancers with prior exposure to anthracyclines and taxanes.

Authors: Daniel Chan; Wee-Lee Yeo; Maricel Tiemsim Cordero; Chiung-Ing Wong; Benjamin Chuah; Ross Soo; Sing-Huang Tan; Siew-Eng Lim; Boon-Cher Goh; Soo-Chin Lee
Journal: Invest New Drugs Date: 2009-08-25 Impact factor: 3.850

Ixabepilone plus capecitabine for metastatic breast cancer progressing after anthracycline and taxane treatment.